Vijay Ramalingam1, Jeff Weinstein2, Ammar Sarwar2, Juan Gimenez3, Muneeb Ahmed2. 1. Division of Vascular and Interventional Radiology, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School , 1 Deaconess Road, Boston, MA, 02215, USA. vramali1@bidmc.harvard.edu. 2. Division of Vascular and Interventional Radiology, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School , 1 Deaconess Road, Boston, MA, 02215, USA. 3. Division of Interventional Radiology, Oschner Clinic, New Orleans, LA, USA.
Abstract
PURPOSE: To describe the feasibility and outcomes of filter-assisted shunt embolization in patients with acquired large portosystemic shunts. METHODS: Two-center HIPAA compliant retrospective study of all patients who underwent filter-assisted shunt embolization between 03/2015-03/2021. Initial clinical evaluation, including demographic information, shunt sizing, and procedural details, was reviewed. Technical success was defined as successful occlusion of the targeted shunt. RESULTS: Eight patients (55 ± 10 years/88% male) had a large acquired portosystemic shunt which was suitable for filter-assisted shunt embolization. Indications for the procedure: 3 = pre-transplantation optimization, 2 = overt hepatic encephalopathy (HE), 1 = post-transplant thrombosis, 1 = portal vein thrombosis and encephalopathy, 1 = encephalopathy and variceal bleeding. Portosystemic shunts occurred between splenic and renal veins, inferior mesenteric and gonadal veins, and coronary veins. Mean shunt diameter was 27 ± 5 mm. The technical success of the procedure was 8/8 (100%). In 7 patients, a transjugular intrahepatic portosystemic shunt (TIPS) was also placed at the time of the shunt embolization due to either pre-transplant indication or sluggish portal flow. There were no intraprocedural complications from filter placement. OUTCOMES: 3 = currently listed for transplant, 2 = resolution of HE, 1 = made CMO, 1 patient with patent post-transplant vasculature. 1 = died as a complication related to TIPS placement (SIR Class F Complication). CONCLUSION: Filter-assisted shunt embolization is a technically feasible and safe technique to reduce or embolize large portosystemic shunts.
PURPOSE: To describe the feasibility and outcomes of filter-assisted shunt embolization in patients with acquired large portosystemic shunts. METHODS: Two-center HIPAA compliant retrospective study of all patients who underwent filter-assisted shunt embolization between 03/2015-03/2021. Initial clinical evaluation, including demographic information, shunt sizing, and procedural details, was reviewed. Technical success was defined as successful occlusion of the targeted shunt. RESULTS: Eight patients (55 ± 10 years/88% male) had a large acquired portosystemic shunt which was suitable for filter-assisted shunt embolization. Indications for the procedure: 3 = pre-transplantation optimization, 2 = overt hepatic encephalopathy (HE), 1 = post-transplant thrombosis, 1 = portal vein thrombosis and encephalopathy, 1 = encephalopathy and variceal bleeding. Portosystemic shunts occurred between splenic and renal veins, inferior mesenteric and gonadal veins, and coronary veins. Mean shunt diameter was 27 ± 5 mm. The technical success of the procedure was 8/8 (100%). In 7 patients, a transjugular intrahepatic portosystemic shunt (TIPS) was also placed at the time of the shunt embolization due to either pre-transplant indication or sluggish portal flow. There were no intraprocedural complications from filter placement. OUTCOMES: 3 = currently listed for transplant, 2 = resolution of HE, 1 = made CMO, 1 patient with patent post-transplant vasculature. 1 = died as a complication related to TIPS placement (SIR Class F Complication). CONCLUSION: Filter-assisted shunt embolization is a technically feasible and safe technique to reduce or embolize large portosystemic shunts.
Authors: Omid Khalilzadeh; Mark O Baerlocher; Paul B Shyn; Bairbre L Connolly; A Michael Devane; Christopher S Morris; Alan M Cohen; Mehran Midia; Raymond H Thornton; Kathleen Gross; Drew M Caplin; Gunjan Aeron; Sanjay Misra; Nilesh H Patel; T Gregory Walker; Gloria Martinez-Salazar; James E Silberzweig; Boris Nikolic Journal: J Vasc Interv Radiol Date: 2017-07-27 Impact factor: 3.464
Authors: Pablo Beltran Miranda; Gonzalo Suarez Artacho; Carmen Bernal Bellido; Luis Miguel Marín Gómez; Carmen Cepeda Franco; Jose María Álamo Martinez; Francisco Javier Padillo Ruiz; Miguel Ángel Gómez Bravo Journal: Transplant Proc Date: 2020-02-10 Impact factor: 1.066
Authors: Ammar Sarwar; Anthony M Esparaz; Elliot B Tapper; Olga R Brook; Douglas Grunwald; Raza Malik; Muneeb Ahmed Journal: AJR Am J Roentgenol Date: 2016-12-13 Impact factor: 3.959
Authors: Michael Praktiknjo; Macarena Simón-Talero; Julia Römer; Davide Roccarina; Javier Martínez; Katharina Lampichler; Anna Baiges; Gavin Low; Elba Llop; Martin H Maurer; Alexander Zipprich; Michela Triolo; Geert Maleux; Annette Dam Fialla; Claus Dam; Judit Vidal-González; Avik Majumdar; Carmen Picón; Daniel Toth; Anna Darnell; Juan G Abraldes; Marta López; Christian Jansen; Johannes Chang; Robert Schierwagen; Frank Uschner; Guido Kukuk; Carsten Meyer; Daniel Thomas; Karsten Wolter; Christian P Strassburg; Wim Laleman; Vincenzo La Mura; Cristina Ripoll; Annalisa Berzigotti; José Luis Calleja; Puneeta Tandon; Virginia Hernandez-Gea; Thomas Reiberger; Agustín Albillos; Emmanuel A Tsochatzis; Aleksander Krag; Joan Genescà; Jonel Trebicka Journal: J Hepatol Date: 2020-01-15 Impact factor: 25.083